Tumor-Microenvironment-Activated DOX@Cu2S@PDA@MnO2 Nanoplatform for MRI/PAI-Assisted Chemophotothermal Therapy of Osteosarcoma
ACS Applied Materials & Interfaces · 04.11.2026 · 18 (43) · 58923-58939
DOI: 10.1021/acsami.6c15245 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 20.10.2026. Verfasst von Tiantian Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong250021, China. Hauptthemen laut MEDLINE: Osteosarcoma, Doxorubicin, Bone Neoplasms, Nanoparticles. Die Arbeit nennt 40 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Natural Science Foundation of Shandong Province, National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Osteosarcoma remains difficult to treat because surgery and chemotherapy can provide incomplete tumor control, cause systemic toxicity, and lack reliable local monitoring. In this study, a tumor-microenvironment-activated DOX@Cu2S@PDA@MnO2 nanoplatform was prepared by converting Cu2O nanocubes into hollow Cu2S, coating polydopamine, growing a MnO2 shell, and loading doxorubicin. The Cu2S/PDA structure enabled strong NIR absorption and drug loading, while MnO2 responded to acidic H2O2/GSH-rich conditions to promote O2 generation, ROS-related reactions, and enhanced T1 MRI contrast. The nanoplatform showed concentration-dependent photothermal conversion at 808 and 1024 nm, microenvironment-responsive DOX release, increased intracellular ROS, and stronger killing of 143B osteosarcoma cells under NIR irradiation than carrier or free-drug controls. In tumor-bearing mice, it enhanced MRI/photoacoustic signals, enabled local photothermal heating, markedly inhibited tumor growth, and increased H&E-defined tumor damage and TUNEL-positive apoptosis, especially with 1024 nm irradiation. Hemolysis, organ histology, hematology, and blood biochemistry indicated acceptable short-term safety after repeated intratumoral administration. These results support this Cu2S/PDA/MnO2-based platform for imaging-guided localized osteosarcoma therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong250021, China.
- Department of Clinical Laboratory, Qilu Hospital of Shandong University, Jinan, Shandong250012, China.
- Department of Spine Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong250021, China.
- Department of Spine Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong250021, China.
ORCID-Profile: Fei Jia
Förderung
- China Postdoctoral Science Foundation
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Wang, T., Liu, C., Yang, H., Li, H., Liu, H., & Jia, F. (2026). Tumor-Microenvironment-Activated DOX@Cu2S@PDA@MnO2 Nanoplatform for MRI/PAI-Assisted Chemophotothermal Therapy of Osteosarcoma. ACS Applied Materials & Interfaces, 18(43), 58923-58939. https://doi.org/10.1021/acsami.6c15245
Vancouver
Wang T, Liu C, Yang H, Li H, Liu H, Jia F. Tumor-Microenvironment-Activated DOX@Cu2S@PDA@MnO2 Nanoplatform for MRI/PAI-Assisted Chemophotothermal Therapy of Osteosarcoma. ACS Applied Materials & Interfaces. 2026;18(43):58923-58939. doi:10.1021/acsami.6c15245
BibTeX
@article{Wang2026,
author = {Wang, Tiantian and Liu, Chen and Yang, Heng and Li, Hengren and Liu, Haoyu and Jia, Fei},
title = {Tumor-Microenvironment-Activated DOX@Cu2S@PDA@MnO2 Nanoplatform for MRI/PAI-Assisted Chemophotothermal Therapy of Osteosarcoma},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
volume = {18},
number = {43},
pages = {58923--58939},
doi = {10.1021/acsami.6c15245}
}
EUVIMED